A detailed history of Index Venture Life Associates Vi LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Index Venture Life Associates Vi LTD holds 9,961,789 shares of CNTA stock, worth $175 Million. This represents 100.0% of its overall portfolio holdings.

Number of Shares
9,961,789
Previous 9,961,789 -0.0%
Holding current value
$175 Million
Previous $48.5 Million 17.45%
% of portfolio
100.0%
Previous 100.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$10.99 - $17.54 $109 Million - $175 Million
9,961,789 New
9,961,789 $112 Million

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.65B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Index Venture Life Associates Vi LTD Portfolio

Follow Index Venture Life Associates Vi LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Index Venture Life Associates Vi LTD, based on Form 13F filings with the SEC.

News

Stay updated on Index Venture Life Associates Vi LTD with notifications on news.